First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysis.
J Oncol Pharm Pract
; 20(5): 362-8, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-24158979
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Drug Costs
/
Hospital Costs
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Year:
2014
Type:
Article